Screener
Charles River Laboratories CRL DSA — Goodwill, Gross
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillGross.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | RMS | DSA (1) | Manufacturing (2) | Total |
|---|---|---|---|---|
| December 27, 2025 | $510,844 | $1,678,518 | $574,891 | $2,764,253 |
| Acquisitions | — | 335,906 | 39,786 | 375,692 |
| Divestitures | — | (37,701) | — | (37,701) |
| Foreign exchange | (551) | (19,320) | (5,522) | (25,393) |
| June 27, 2026 | $510,293 | $1,957,403 | $609,155 | $3,076,851 |
| (1) DSA includes accumulated impairment losses of $1 billion, which were recognized in fiscal years 2008 and 2010. | ||||
| (2) Manufacturing includes accumulated impairment losses of $380 million, which were recognized in fiscal years 2024 and 2025. |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's DSA — goodwill, gross?
- Charles River Laboratories (CRL) reported DSA — goodwill, gross of $1.96B in Q2 2026.
- What does DSA — goodwill, gross mean?
- Represents the premium paid over the fair market value of net assets during acquisitions attributed to this segment. It reflects the value of intangible factors like brand reputation and customer base acquired through M&A.
Ask your AI about Charles River Laboratories's dsa — goodwill, gross.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude